FDA Grants Priority Review of Talecris Biotherapeutics’s Gamunex(R) as a Treatment for Neurological Disorder CIDP 5/9/2008
Cut and paste this URL for the story. http://www.biospace.com/news_story.aspx?StoryID=95699&full=1
You must be logged in to reply to this topic.